Accuitis' Angel Round

Accuitis raised a round of funding on March 20, 2015. Investors include Bio/Med Investor Network.

Accuitis is engaged in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company's lead product is a transformational first in class treat…

Articles about Accuitis' Angel Round: